Skip to main content
. 2023 Nov 4;13(1):161–178. doi: 10.1007/s40123-023-00829-3

Table 2.

Reasons for end of observation in the global diabetic macular edema cohort

Reason, n (%) Treatment-naïve (n = 1478) Previously treated (n = 384)
Planned end of study 836 (56.6) 236 (61.5)
Death 21 (1.4) 4 (1.0)
Lost to follow-up 374 (25.3) 121 (31.5)
Withdrawal by patient 15 (1.0) 1 (0.3)
Pregnancy 1 (0.1) 0
Switching to other therapy 126 (8.5) 13 (3.4)
Physician decision 8 (0.5) 2 (0.5)
Other 60 (4.1) 2 (0.5)
Missing 37 (2.5) 5 (1.3)